Currently, out of the existing stock ratings of Pete Stavropoulos - 16 which are a Buy (100%)

Pete Stavropoulos

Work Performance Price Targets & Ratings Chart

Analyst Pete Stavropoulos works at CANTOR FITZGERALD and is covering the Healthcare sector with 23 price targets and ratings displayed on 5 stocks.

Pete Stavropoulos's average stock forecast success ratio is 25% with an average time for price targets to be met of 48 days.

Most recent stock forecast was given on ARCT, Arcturus Therapeutics Holdings at 22-Aug-2023.

Wall Street Analyst Pete Stavropoulos

Analyst best performing recommendations are on PLRX.
The best stock recommendation documented was for PLRX at 7/26/2022. The price target of $36 was fulfilled within 184 days with a profit of $18.36 (104.08%) receiving and performance score of 5.66.

Average potential price target upside

  • of $15.68 (80.3%) on PLRX.
ANNX PLRX ARCT Arcturus Therapeutics Holdings ORTX Orchard Therapeutics plc RZLT

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$13.66 (583.76%)

22 days ago

0/2 (0%)

$12.98 (349.85%)



$27.64 (1171.19%)


3 months 27 days ago

0/5 (0%)

$25.84 (697.34%)



$1.66 (70.94%)


4 months 4 days ago

1/2 (50%)

$0.31 (9.13%)




$7.23 (408.47%)

6 months 10 days ago

0/1 (0%)

$6.9 (328.57%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Pete Stavropoulos is most bullish on?

Potential upside of $29.13 has been obtained for ARCT (ARCTURUS THERAPEUTICS HOLDINGS)

Which stock is Pete Stavropoulos is most reserved on?

Potential downside of -$0 has been obtained for ANNX

What Year was the first public recommendation made by Pete Stavropoulos?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart